Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,062.50    25.50 (2.46%)
Bid:
1,062.50
Ask:
1,063.00
Spread: 0.50 (0.047%)
Market Cap: £3.41b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Director/PDMR Shareholding

3 Jun 2014 15:46

RNS Number : 7482I
Persimmon PLC
03 June 2014
 

3 June 2014

 

Directors' Shareholdings

 

Persimmon plc (the "Company") announces that on 2 June 2014 the Executive Directors detailed below exercised the following options over shares awarded to them under the Company's Bonus Share Scheme and Long Term Incentive Plan 2007 ("LTIP 2007"):

 

Name

Number of Shares Acquired

Scheme

Exercise Price

Jeff Fairburn

13,493

Bonus Share Scheme

Nil

10,510

Bonus Share Scheme

Nil

99,601

LTIP 2007

Nil

 

Mike Killoran

19,277

Bonus Share Scheme

Nil

12,889

Bonus Share Scheme

Nil

142,297

LTIP 2007

 

Nil

Nigel Greenaway

22,133

LTIP 2007

 

Nil

David Jenkinson

11,066

LTIP 2007

Nil

1,255

LTIP 2007

Nil

7,530

LTIP 2007

£3.984

2,213

LTIP 2007

Nil

Also on 2 June 2014, David Jenkinson sold 2,213 shares to fund option exercise costs. In addition, Jeff Fairburn transferred 51,086 shares in the Company to his wife Jayne and 48,360 to a family trust all for nil consideration.

As a result of these transactions, the Executive Directors beneficial holdings (including interests of each Executive Directors' connected persons) in Ordinary shares are as follows:

 

Name

Beneficial

Holding

Percentage of issued share capital

 

Jeff Fairburn

201,514

0.07%

Mike Killoran

724,588

0.24%

 

Nigel Greenaway

63,557

0.02%

 

David Jenkinson

36,448

0.01%

 

Jeff Fairburn and Mike Killoran also each have a non-beneficial interest in 48,360 and 64,022 shares respectively.

 

Following the Bonus Share Scheme options exercises set out above, Persimmon (Share Scheme Trustees) Limited holds 143,886 shares in the Company representing 0.05% of the issued share capital. These shares are held in an employee benefit trust for the Company's Bonus Share Scheme. Each of the executive directors of the Company is a potential participant under the Bonus Share Scheme and is therefore regarded as having a notional interest in these shares.

 

The issued share capital of the Company on 3 June 2014 was 305,797,551 ordinary shares.

 

 

G N Francis

Group Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEALKDELSLEFF
Date   Source Headline
1st May 20252:20 pmRNSResult of AGM
1st May 20252:02 pmRNSTotal Voting Rights
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.